SRT3.DE Sartorius AG (preference shares) Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
00:49
Jan 08
Jan 08
Biologics equipment benefits from AI drug discovery.
Within healthcare he is selective and only invests in biologics. He owns Danaher and Sartorius, which supply manufacturing equipment for biologics used by biotech companies. He believes AI will accelerate drug discovery, and over about 10 years personalized drugs will grow versus chemical/synthetic drugs; the sector has lagged but should do well.
MED
About SRT3.DE Investor Commentary
Across the available history and selected sources, Buzzberg tracks SRT3.DE (Sartorius AG (preference shares)) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Stephen Yiu.